Assessment of physician behaviour regarding metabolic monitoring of patients treated with SEROQUEL® (quetiapine fumarate) Tablets and SEROQUEL® (quetiapine fumarate) Extended Release Tablets in selected countries in the European Union (EU)

First published 01/02/2013

Last updated 02/04/2024

EU PAS number:

EUPAS3287

Study

Finalised

Documents

Study protocol

Initial protocol

D1443C00127 Risk Minimization Physician Survey Protocol1

English (1.17 MB - PDF) View document

Study results

D1443C00127 Clinical Study Report

English (404.57 KB - PDF) View document

Study report

Other information

Publications

Study publications

Secondary tabs